These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21864590)

  • 1. Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope.
    Mazeike E; Gedvilaite A; Blohm U
    Virus Res; 2012 Jan; 163(1):2-10. PubMed ID: 21864590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.
    Storni T; Lechner F; Erdmann I; Bächi T; Jegerlehner A; Dumrese T; Kündig TM; Ruedl C; Bachmann MF
    J Immunol; 2002 Mar; 168(6):2880-6. PubMed ID: 11884458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
    Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
    Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an epitope-specific CD8+ T-cell response on murine coronavirus central nervous system disease: protection from virus replication and antigen spread and selection of epitope escape mutants.
    Chua MM; MacNamara KC; San Mateo L; Shen H; Weiss SR
    J Virol; 2004 Feb; 78(3):1150-9. PubMed ID: 14722270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and humoral immunogenicity of hamster polyomavirus-derived virus-like particles harboring a mucin 1 cytotoxic T-cell epitope.
    Dorn DC; Lawatscheck R; Zvirbliene A; Aleksaite E; Pecher G; Sasnauskas K; Ozel M; Raftery M; Schönrich G; Ulrich RG; Gedvilaite A
    Viral Immunol; 2008 Mar; 21(1):12-27. PubMed ID: 18355119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells.
    Gallimore A; Hombach J; Dumrese T; Rammensee HG; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Oct; 28(10):3301-11. PubMed ID: 9808199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2Db but not H-2Kb.
    Puglielli MT; Zajac AJ; van der Most RG; Dzuris JL; Sette A; Altman JD; Ahmed R
    J Virol; 2001 Jun; 75(11):5099-107. PubMed ID: 11333891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of CD8 T Cell-Mediated Mutations in the Immunodominant Epitope GP33-41 of Lymphocytic Choriomeningitis Virus.
    Smyth M; Khamina K; Popa A; Gudipati V; Agerer B; Lercher A; Kosack L; Endler L; Baazim H; Viczenczova C; Huppa JB; Bergthaler A
    Front Immunol; 2021; 12():638485. PubMed ID: 34194424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.
    Velloso LM; Michaëlsson J; Ljunggren HG; Schneider G; Achour A
    J Immunol; 2004 May; 172(9):5504-11. PubMed ID: 15100292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
    Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
    J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells efficiently induce protective antiviral immunity.
    Ludewig B; Ehl S; Karrer U; Odermatt B; Hengartner H; Zinkernagel RM
    J Virol; 1998 May; 72(5):3812-8. PubMed ID: 9557664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
    Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
    J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effector cell function and altered tetramer binding of tumor-infiltrating lymphocytes.
    Blohm U; Roth E; Brommer K; Dumrese T; Rosenthal FM; Pircher H
    J Immunol; 2002 Nov; 169(10):5522-30. PubMed ID: 12421928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences.
    Zimmermann C; Prévost-Blondel A; Blaser C; Pircher H
    Eur J Immunol; 1999 Jan; 29(1):284-90. PubMed ID: 9933110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo.
    Prévost-Blondel A; Roth E; Rosenthal FM; Pircher H
    J Immunol; 2000 Apr; 164(7):3645-51. PubMed ID: 10725721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2D Kinetic Analysis of TCR and CD8 Coreceptor for LCMV GP33 Epitopes.
    Kolawole EM; Andargachew R; Liu B; Jacobs JR; Evavold BD
    Front Immunol; 2018; 9():2348. PubMed ID: 30374353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-based vaccine against Listeria monocytogenes: extending the concept of invariant chain linkage.
    Jensen S; Steffensen MA; Jensen BA; Schlüter D; Christensen JP; Thomsen AR
    J Immunol; 2013 Oct; 191(8):4152-64. PubMed ID: 24043891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections.
    Bahl K; Kim SK; Calcagno C; Ghersi D; Puzone R; Celada F; Selin LK; Welsh RM
    J Immunol; 2006 Apr; 176(7):4284-95. PubMed ID: 16547266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus.
    Kotturi MF; Peters B; Buendia-Laysa F; Sidney J; Oseroff C; Botten J; Grey H; Buchmeier MJ; Sette A
    J Virol; 2007 May; 81(10):4928-40. PubMed ID: 17329346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.